Vir Biotechnology, Inc. Quarterly Revenue from Contract with Customer, Excluding Assessed Tax in USD from Q1 2024 to Q2 2025
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.
-
Summary
-
Vir Biotechnology, Inc. quarterly/annual Revenue from Contract with Customer, Excluding Assessed Tax history and growth rate from Q1 2024 to Q2 2025.
- Vir Biotechnology, Inc. Revenue from Contract with Customer, Excluding Assessed Tax for the quarter ending June 30, 2025 was $1.21M, a 60.5% decline year-over-year.
- Vir Biotechnology, Inc. annual Revenue from Contract with Customer, Excluding Assessed Tax for 2024 was $74.2M, a 13.9% decline from 2023.
- Vir Biotechnology, Inc. annual Revenue from Contract with Customer, Excluding Assessed Tax for 2023 was $86.2M, a 94.7% decline from 2022.
Revenue from Contract with Customer, Excluding Assessed Tax, Quarterly (USD)
Revenue from Contract with Customer, Excluding Assessed Tax, YoY Quarterly Growth (%)